U
Medite Cancer Diagnostics, Inc. MDIT
$0.00 $0.000.00%
Recommendation
--
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)
--

09/30/2018 06/30/2018 03/31/2018 12/31/2017 09/30/2017
Net Income -2.07% -58.10% -190.79% -214.89% -203.02%
Total Depreciation and Amortization 2.93% 52.31% 48.58% 36.92% 15.68%
Total Amortization of Deferred Charges 975.26% 1,462.86% 475.93% -47.24% -127.09%
Total Other Non-Cash Items -79.89% -35.89% -10.86% 95.16% 705.70%
Change in Net Operating Assets -163.73% -107.03% 379.58% 1,363.57% 1,282.53%
Cash from Operations -187.43% -177.60% -287.85% -227.13% -58.98%
Capital Expenditure 20.30% 20.14% -3.45% -16.52% 37.85%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- -177.78%
Cash from Investing 34.16% -217.14% -224.32% -16.52% 9.55%
Total Debt Issued -21.55% 14,022.64% 1,622.19% 1,262.02% 418.44%
Total Debt Repaid 79.78% -764.13% -1,513.73% -4,687.50% -2,219.29%
Issuance of Common Stock -93.28% -79.45% -6.51% 479.31% --
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -582.85% -582.85% -582.85% -582.85% -210.36%
Cash from Financing -31.81% 123.58% 161.33% 451.14% 328.17%
Foreign Exchange rate Adjustments 180.95% 216.13% 192.07% 651.85% -1,197.06%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -195.48% -232.83% -127.22% 174.74% 739.68%
Weiss Ratings